WallStreetZenWallStreetZen

NASDAQ: IOSP
Innospec Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Innospec earnings were $116.6M for the trailing 12 months ending Dec 31, 2025, with 228% growth year over year. The latest IOSP earnings report on Dec 31, 2025 announced Q4 2025 earnings of $47.4M, up 267.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IOSP reported annual earnings of $116.6M, with 227.5% growth. The next IOSP earnings date is May 6, 2026.

IOSP past earnings growth

How has IOSP's earnings growth performed historically?

Company
227.97%
Industry
1.38%
Market
87.13%
IOSP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
IOSP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
IOSP's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

IOSP earnings history

Current Revenue
$1.8B
Current Earnings
$116.6M
Current Profit Margin
6.6%
IOSP's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

IOSP Return on Equity

Current Company
9%
Current Industry
16.6%
Current Market
29.4%
IOSP's Return on Equity (9%)... subscribe to Premium to read more.
High Return on Equity Performance

IOSP Return on Assets

Current Company
6.5%
Current Industry
5.4%
IOSP is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IOSP announces earnings.

IOSP Return on Capital Employed

Current Company
8.76%
Current Industry
10.2%
IOSP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IOSP vs Specialty Chemical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IOSP$172.50M$116.60M+32.01%$4.69
WTTR$222.61M$21.22M-83.79%$0.21
ECVT$61.17M-$71.13MN/A-$0.62
KWR$159.62M-$2.49MN/A-$0.14
MTX$132.20M-$18.40MN/A-$0.59
View Top Specialty Chemical Stocks

IOSP earnings dates

Next earnings date
May 6, 2026

Innospec Earnings Reports & History FAQ

What were Innospec's earnings last quarter?

On IOSP's earnings call on Invalid Date, Innospec (NASDAQ: IOSP) reported Q4 2025 earnings per share (EPS) of $1.91, up 167.73% year over year. Total IOSP earnings for the quarter were $47.40 million. In the same quarter last year, Innospec's earnings per share (EPS) was -$2.82.

If you're new to stock investing, here's how to buy Innospec stock.

When does Innospec report earnings?

The next IOSP earnings call is Invalid Date. Add IOSP to your watchlist to be reminded of Innospec's next earnings date.

Is Innospec profitable or losing money?

As of the last Innospec earnings report, Innospec is currently profitable. Innospec's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $116.60 million, a 227.53% increase year over year.

What was IOSP's earnings growth in the past year?

As of Innospec's earnings date in Invalid Date, Innospec's earnings has grown 227.97% year over year. This is 226.6 percentage points higher than the US Specialty Chemicals industry earnings growth rate of 1.38%. IOSP earnings in the past year totalled $116.60 million.

What are Innospec's earnings expectations?

The current EPS estimate for Innospec's earnings report in Invalid Date is $1.32.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.